CH
Chemed
CHE · NYSE
$520.33 -0.79% (-$4.12)
1M -5.38%
Market Cap $6.85B
P/E Ratio 24.93x
Div. Yield 0.48%
ROE 29.45%
Bulios Fair Price
$330.69
36.4% downside
Current Price
$520.33
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CHE is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
46 /100
Fair P/FCF 21.18x
P/E 24.93x
P/B 8.25x
Growth
50 /100
Stable FCF growth 8.82%
EPS growth 3.67%
Book val. growth 7.03%
Profitability
65 /100
Moderate Op. margin 13.46%
Gross margin 30.44%
FCF margin 12.47%
Quality
99 /100
Excellent ROA 17.41%
ROIC 19.48%
Asset turnover 1.64x
Debt
86 /100
Low Int. coverage 75.74x
Debt/Equity 0.40x
Net debt/EBITDA 0.67x
Stability
95 /100
Stable EPS volatility 9.94%
Beta 0.51x
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CHE
Online
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Kevin J. McNamara
Employees
15,811
Headquarters
Cincinnati
Upcoming events
27 OCT
Earnings
Upcoming earnings report